Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic Cancer

Newsfeed Image, Light Gray Text On Dark Gray Background
A growing body of preclinical data suggests that statins may exert potent antitumor effects, yet the interactions of these medications with standard therapies and clinical outcomes in this population is less clear. We assessed the impact of statin use on outcomes in patients with advanced-stage pancreatic adenocarcinoma undergoing various treatments

Read more . . .